Ascrinvacumab (PF-03446962) is a monoclonal antibody designed for the treatment of cancer.Statement On A Nonproprietary Name Adopted By The USAN Council -…
Ascrinvacumab (PF-03446962) is a monoclonal antibody designed for the treatment of cancer.Statement On A Nonproprietary Name Adopted By The USAN Council - Ascrinvacumab, American Medical Association. It is an ALK1 inhibitor.
This drug was developed by Pfizer Inc.
References
Gebaseerd op: Wikipedia — Ascrinvacumab · auteursgeschiedenis.
Tekst: CC BY-SA 4.0.
Wikisyntaxis en sjablonen zijn verwijderd; langere teksten zijn ingekort.